Apotheek Antverpia
ActiveSummary
Apotheek Antverpia has been active since 1968 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €4.33M and a net result of €449k. Equity is growing by ~7.1% per year across the filed fiscal years. Its solvency ranks better than 42% of 6537 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 1.2% (low).
Checked score
Score 2024
52
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability58▲+30
Solvency51▲+14
Growth77▲+12
Track record100
Bankruptcy probability, 12 months
1.2%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €220k at 30 days acceptable
Liquidity tight (current ratio 1.27 against 1.04 in 2023; short-term debt: 63.9% and cash: 4.4% of total assets), and 73.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
26.2%
Return on assets
2.7%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
29 d late
2023
30 d late
2022
32 d late
2021
78 d late
2020
82 d late
2019
27 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, full schema
Turnover
€65.58M▼ 0.5%
2023 · €65.93M
2019: €35.56M
2020: €48.65M
2021: €57.36M
2022: €62.40M
2023: €65.93M
2019 → 2024
EBIT margin
1.1%▲ 1.9pp
2023 · -0.7%
2019: 1.2%
2020: 2.4%
2021: 0.9%
2022: 0.6%
2023: -0.7%
2019 → 2024
Net result
€449k
2023 · €-512k
2019: €252k
2020: €1.57M
2021: €341k
2022: €208k
2023: €-512k
2019 → 2024
Working capital
€2.88M▲ 199%
2023 · €962k
2019: €300k
2020: €1.41M
2021: €1.85M
2022: €1.70M
2023: €962k
2019 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Turnover€48.65M-€57.36M▲ 17.9%€62.40M▲ 8.8%€65.93M▲ 5.7%€65.58M▼ 0.5%
Equity€3.68M-€4.02M▲ 9.3%€4.23M▲ 5.2%€3.72M▼ 12.1%€4.33M▲ 16.6%
Operating result€1.15M-€524k▼ 54.3%€348k▼ 33.7%€-494k€745k
Net result€1.57M-€341k▼ 78.3%€208k▼ 39.0%€-512k€449k
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2024: €745k after a loss of €494k in 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €16.56M
Fixed assets
€3.10M ▼ 32.4%
Current assets
€13.46M ▼ 46.7%
Equity and liabilities €16.56M
Equity
€4.33M ▲ 16.6%
Debt
€12.22M ▼ 53.2%
Debt's share of the balance-sheet total falls from 87.6% to 73.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€1.46M▲
2023 · €76k
Cash flow
€1.17M▲
2023 · €59k
Current ratio
1.27▲
2023 · 1.04
Quick ratio
0.82▼
2023 · 0.85
Debt to equity
2.82▼
2023 · 7.03
ROE
10.4%▲
2023 · -13.8%
ROA
2.7%▲
2023 · -1.7%
Interest coverage
17.65▲
2023 · 1.90
Debt ≤ 1 year
€10.58M▼
2023 · €24.31M
Debt > 1 year
€1.50M▼
2023 · €1.74M
Income taxes
€387k▲
2023 · €4k
Staff costs
€7.58M▲
2023 · €6.29M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 82 lines
Balance sheet
Code20232024
Assets
Total assets20/58€29.85M€16.56M▼
Fixed assets21/28€4.58M€3.10M▼
Intangible fixed assets21€563k€488k▼
Tangible fixed assets22/27€2.77M€2.54M▼
Land and buildings22€1.31M€1.23M▼
Plant, machinery and equipment23€1.17M€1.02M▼
Furniture and vehicles24€291k€288k▼
Financial fixed assets28€1.25M€67k▼
Affiliated companies280/1€1.24M€48k▼
Participating interests280€1.24M€48k▼
Other financial fixed assets284/8€14k€19k▲
Amounts receivable and cash guarantees285/8€14k€19k▲
Current assets29/58€25.27M€13.46M▼
Stocks and contracts in progress3€4.55M€4.75M▲
Stocks30/36€4.55M€4.75M▲
Goods purchased for resale34€4.55M€4.75M▲
Amounts receivable within one year40/41€20.33M€7.88M▼
Trade receivables40€19.66M€6.42M▼
Other amounts receivable41€666k€1.46M▲
Current investments50/53€13k€13k=
Other investments51/53€13k€13k=
Cash at bank and in hand54/58€296k€725k▲
Deferred charges and accrued income490/1€84k€83k▼
Equity and liabilities
Total equity and liabilities10/49€29.85M€16.56M▼
Equity10/15€3.72M€4.33M▲
Contributions10/11€62k€82k▲
Capital10€62k€82k▲
Issued capital100€62k€82k▲
Reserves13€3.65M€4.25M▲
Non-distributable reserves130/1€24k€24k=
Legal reserve130€24k€24k=
Tax-exempt reserves132€56k€56k=
Distributable reserves133€3.57M€4.17M▲
Amounts payable17/49€26.14M€12.22M▼
Amounts payable after more than one year17€1.74M€1.50M▼
Financial debts170/4€1.74M€1.50M▼
Credit institutions173€1.74M€1.50M▼
Amounts payable within one year42/48€24.31M€10.58M▼
Current portion of amounts payable after more than one year42€238k€269k▲
Financial debts43€500k€305k▼
Other loans439€500k€305k▼
Trade debts44€21.52M€7.97M▼
Suppliers440/4€21.52M€7.97M▼
Taxes, remuneration and social security45€1.12M€1.42M▲
Taxes450/3€401k€685k▲
Remuneration and social security454/9€722k€733k▲
Other amounts payable47/48€931k€611k▼
Accrued charges and deferred income492/3€90k€142k▲
Income statement
Code20232024
Operating income70/76A€68.48M€68.35M▼
Turnover70€65.93M€65.58M▼
Other operating income74€2.55M€2.77M▲
Operating charges60/66A€68.97M€67.61M▼
Goods for resale, raw materials and consumables60€52.45M€47.87M▼
Purchases600/8€55.63M€47.72M▼
Change in stocks: decrease (increase)609€-3.18M€145k▲
Services and other goods61€9.61M€10.41M▲
Remuneration, social security and pensions62€6.29M€7.58M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€571k€717k▲
Other operating charges640/8€46k€42k▼
Non-recurring operating charges66A€3k€991k▲
Operating profit (loss)9901€-494k€745k▲
Financial income75/76B€45k€178k▲
Recurring financial income75€18k€15k▼
Income from current assets751-€187
Other financial income752/9€18k€14k▼
Non-recurring financial income76B€26k€164k▲
Financial charges65/66B€58k€87k▲
Recurring financial charges65€58k€87k▲
Debt charges650€40k€83k▲
Other financial charges652/9€17k€4k▼
Profit (loss) for the period before taxes9903€-507k€836k▲
Income taxes67/77€4k€387k▲
Taxes670/3€92k€387k▲
Tax adjustments and reversals of tax provisions77€88k€40▼
Profit (loss) for the period9904€-512k€449k▲
Profit (loss) for the period to be appropriated9905€-512k€449k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-512k€449k▲
Transfer from equity791/2€512k-
From reserves792€512k-
Transfer to equity691/2-€449k
To other reserves6921-€449k
Social balance
Average headcount (FTE)9087123.9172.5▲
The notes to these accounts (56 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 29 days late
2024
31-12
Financial
Back to profitnet €449k
Net result €449k after one loss-making year.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 30 days late
2023
31-12
Financial
Weakest financial yearnet €-512k ▼346%
Net result drops to €-512k, the lowest in the series; recovery starts the following year.
01-09
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 32 days late
2022
17-10
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 78 days late
2021
21-10
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 82 days late
2020
31-12
Financial
Highest result since 2019net €1.57M ▲524%
Operating result €1.15M, net result €1.57M, both a record.
27-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 27 days late
2019
13-06
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
22-06
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
26-09
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 57 days late
2016
30-09
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 61 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
12 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kontich · 11 establishment units since 1961
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Blauwesteenstraat 952550 KontichGround area
1.3 ha
Building footprint
9,773 m²
Volume, LiDAR
70,581 m³
12 parcels, Flanders · tallest building 22.3 m, ±6 floors. Linked by address, not a title deed.
11 establishment units
Apotheek Antverpia
since 19612.004.206.080
Apotheek Antverpia
since 19612.004.206.179
Apotheek Antverpia
since 19612.004.206.278
Apotheek Antverpia
since 19612.004.206.377
Apotheek Antverpia
since 19612.004.205.981
Apotheek Antverpia
since 19772.014.006.446
Show 5 more locations
Apotheek Antverpia
since 19902.004.206.476
Apotheek Antverpia
since 19952.071.173.989
Apotheek Antverpia
since 20072.169.082.821
Apotheek Antverpia Kontich
since 20222.330.983.937
Apotheek Antverpia Lier
since 20222.330.984.036
12 parcels
Flanders
12
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11602E0062/00Z000 | Flanders | 8,646 m² | 1 · 7,560 m² | 12.3 m · 2 fl. |
| 11472B0136/00G005 | Flanders | 929 m² | 1 · 365 m² | 8.8 m |
| 11602E0035/00N015 | Flanders | 729 m² | 1 · 30 m² | 11.1 m |
| 11003A0230/00C006 | Flanders | 723 m² | 1 · 462 m² | 22.2 m · 6 fl. |
| 43018D0493/00A000 | Flanders | 612 m² | 1 · 323 m² | 13.9 m · 4 fl. |
| 11513C0280/00A004 | Flanders | 295 m² | 1 · 295 m² | 19.1 m · 4 fl. |
| 11028A0148/00X002 | Flanders | 234 m² | 1 · 129 m² | 17.8 m · 5 fl. |
| 24502B0135/00L003 | Flanders | 232 m² | 1 · 198 m² | 19.2 m · 4 fl. |
| 12403D0082/00R004 | Flanders | 224 m² | 1 · 218 m² | 14.9 m · 2 fl. |
| 11021A0161/00N004 | Flanders | 162 m² | - | - |
| 11804D2384/00H000 | Flanders | 138 m² | 1 · 120 m² | 20.6 m · 6 fl. |
| 12393F0330/00L004indicative | Flanders | 126 m² | 1 · 71 m² | 6.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 11
11 of 12 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Public money · subsidies and aid
Flemish government
2022 to 2025 · 12 entries · 51,635 EUR awarded · 51,046 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 2 | 8,070 EUR | 7,881 EUR |
| 2024 | 3 | 11,506 EUR | 11,506 EUR |
| 2023 | 5 | 19,049 EUR | 18,877 EUR |
| 2022 | 2 | 13,010 EUR | 12,782 EUR |
Schemes
Vlaamse ondersteuningspremie (VOP) voor werkgevers (uitdovend stelsel)
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Vlaams opleidingsverlof (VOV)
Recognitions · licences · registrations
Food safety, FASFC
9 sitesAntwerpen2.004.205.981
Antwerpen2.014.006.446
Edegem2.004.206.080
Hove2.004.206.179
Show 5 more sites
Kontich2.330.983.937
Leuven2.071.173.989
Mechelen2.004.206.476
Mortsel2.004.206.278
Zelzate2.169.082.821
Similar companies · same sector, comparable size
ANTWERP PHARMACIES
BE 0700.733.344
Sint-Truiden · Eq €4.32M
PHARMACIE HOUBA
BE 0891.466.622
Brussel · Eq €4.28M
Popelin Apotheken
BE 1004.967.609
Anderlecht · Eq €4.27M
Superphar
BE 0406.879.465
Namur · Eq €4.16M
IMBEFRANCE
BE 0443.801.328
Halle · Eq €4.14M
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 1,253 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded01-01-1968
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 48 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.